Enlivex Therapeutics
ENLV
ENLV
23 hedge funds and large institutions have $11.7M invested in Enlivex Therapeutics in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.76% more ownership
Funds ownership: 2.96% → 6.72% (+3.8%)
61% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $2.6M
Holders
23
Holding in Top 10
–
Calls
$1.01M
Puts
$2.6M
Top Buyers
| 1 | +$5.28M | |
| 2 | +$376K | |
| 3 | +$267K | |
| 4 |
GG
Golden Green
Seneca,
South Carolina
|
+$263K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$197K |